Animalcare Ltd has launched Tilmodil (tilmicosin 300mg/ml solution for injection), a semi-synthetic macrolide antibiotic licensed for pneumonia in cattle and sheep, foul in the foot in cattle, and footrot and mastitis in sheep.
According to the company, Tilmicosin is fast-acting1, long-acting2 and highly effective against the major Gram-ve bovine respiratory pathogens.2,3 In addition, the company says tissue penetration is excellent.1 In calves a single SC injection at 10mg/kg bw results in lung concentrations exceeding the MIC90 of Mannheimia haemolytica for 72 hours.2
Animalcare says that pooled data from greater than 6000 cattle has confirmed the effectiveness of tilmicosin in the treatment of bovine respiratory disease (BRD) in well-controlled, randomised field studies. Tilmodil treatment has been proven equally effective compared to antibiotics, such as florfenicol, marbofloxacin and danofloxacin.
A recent report by the Farm Animal Welfare Council estimates that three million of the national sheep flock are lame at any one time. It is estimated that footrot is responsible for greater than 90% of lameness and is present in 97% of flocks. Tilmicosin has good activity against the key Gram-ve pathogens2 and has been successfully used in the treatment of footrot.4
Tilmodil has been developed for animal use only and is administered by veterinary surgeons only. Dosage is 1ml per 30kg bw for respiratory disease and mastitis in sheep and 0.5ml per 30kg bw for interdigital necrobacillosis (foul in the foot/footrot/bovine pododermatitis).
Tilmodil is administered as a single, low volume subcutaneous (SC) injection dose and presented in 50ml multi-dose vials.
References
1. Apley M., Antimicrobial therapy of Bovine Respiratory Disease.Veterinary Clinics of North America.Food Animal Practice (1997) 13,3:159-5622. Tilmodil SPC3. Giguere S et al .,Antimicrobial therapy in Veterinary Medicine.4th edition 2006.Chp.12,2014. Winter A., Lameness in sheep. 2. Treatment and control. In Practice (2004),3, 130-139.
Pete (pictured right), an RCVS Recognised Specialist in Veterinary Dentistry, was recognised for his outstanding contributions to the discipline of veterinary oral and maxillofacial surgery (OMFS).
There are a total of 14 founding fellows and Pete is the only one practising in Europe. The award will mean it’s possible for an OMFS Fellowship programme to be delivered at Eastcott Referrals in the future.
Pete said: "To be accepted as an AVDC Fellow is a real honour and I’m delighted to be awarded this position. There is a pretty rigorous process to go through to become a Founding Fellow of the AVDC, so it’s extremely gratifying to be recognised."
At the same time, another Eastcott clinician is also celebrating recognition in the same discipline: Andrew Perry has become a European Veterinary Specialist in Dentistry.
Pete said: "We all congratulate Andrew on his achievement. He is a hugely valuable and experienced member of the team here.
"It’s a very exciting time for Eastcott, as we seek to expand our dentistry and oral and maxillofacial surgery department and develop new techniques in OMFS.
"We have a highly experienced team and will adding another Resident in the new year, so we’re in an extremely strong position to deal with a large caseload and able to see a wide range of different cases."
For more information about Eastcott Referrals, visit www.eastcottreferrals.co.uk.
Tuloxxin contains Tulathromycin and Krka says it is based on the same formulation as the market leader.
In cattle Tuloxxin is administered using a single subcutaneous injection; in sheep Tuloxxin is licensed for use in the treatment of foot rot associated with Dichelobacter nodosus and also in pigs for swine respiratory disease (SRD) administered via a single intra-muscular injection. Krka says it is fast-acting, and that the one dose formulation supports compliance and so reduces stress to herds and flocks.
Charlotte Read, Key Account Manager – Farm, at Krka, said: "Whenever Krka launches a generic product, we aim to add some extra value to it. Tuloxxin is a good example. It is based on a tried and trusted active and delivers efficacy; with formulation and delivery method technology at exceptional value. We hope its launch will support vets in their appropriate choice of antibiotic for specific cases. In so doing, they will be protecting their clients’ cattle and profitability while also playing their part in reducing antimicrobial use.”
Tuloxxin is available now from all wholesalers.
Bovilis Bovivac S is used for active immunisation to induce serological and colostral antibody production against Salmonella Dublin and Salmonella Typhimurium.
In the face of an outbreak, it can also be used to reduce Salmonella Typhimurium infections when used as part of an overall herd management programme.
MSD says Bovilis Bovivac S may also contribute to reducing S. Typhimurium contamination of the environment. Other than the packaging, the vaccine itself is identical.
PBD says Bovine tuberculosis (bTB) is a growing problem for zoos and wildlife parks, especially with the disease’s potential to spread from one species to another, creating a natural reservoir that is difficult to control.
bTB in zoos came to public attention last year when Devon’s Paignton Zoo detected a single case in one of its antelope. Without access to a test that would deliver rapid results, the zoo had to cull the remaining 10-strong herd of Kafue Flats lechwe.
PBD says the Actiphage test can identify bTB and other mycobacterial diseases in animals before clinical symptoms of infection are observed. It can detect with high specificity the presence of any mycobacteria in animal blood within 6 hours in comparison to culturing mycobacteria, which can take up to 12 weeks.
The technology has been successfully applied to blood samples from 17 different species so far, including deer, goats and badgers as well as exotic animals such as lions, giraffes, antelopes, elephants, tigers, kangaroos and camels. Trials have confirmed PBD Biotech’s assay can detect live mycobacteria in blood or milk samples at very high sensitivity, of less than 10 mycobacterial cells per ml of sample.
The test is being presented to delegates at the British Veterinary Zoological Society (BVZS) Congress in Birmingham today by Dr Ben Swift, Research Fellow at the Royal Veterinary College and R&D Director at PBD Biotech.
He said: "The Actiphage detection method provides a major step change in the detection of viable mycobacteria and has the potential to revolutionise the control and understanding of mycobacterial diseases in zoo animals, wildlife and a range of other species.
"The use of bacteriophage means the test can detect mycobacteria before an immune response is fully developed, giving vets, zoo-keepers and other exotics experts a head-start on the race to catch bTB and other diseases in the hope of preventing the unnecessary cull of protected animals."
Domingo, pictured on the left with Southfields clinical director Henry L’Eplattenier, will join the Essex referral centre as head of cardiopulmonary service at the start of February.
After qualifying in Zaragoza in his native Spain, Domingo completed an internship and several years in practice in the UK, before joining the University of Bristol small animal hospital as a resident.
He then completed a three-year training programme in small animal internal medicine, followed by a four-year programme in cardiology to become an RCVS diplomate and specialist in veterinary cardiology and small animal internal medicine (ECVIM).
After being appointed as head of cardiology and respiratory medicine at Bristol, Domingo joined Dick White Referrals before his move to Southfields.
Domingo said: "I’m delighted to be joining such a progressive and forward-thinking practice as Southfields. It is clear everyone at the practice is dedicated to continuing its growth and dedication to providing the highest possible level of care."
Southfields’ operations manager Daniel Hogan said: "The arrival of Domingo adds another hugely talented specialist to our growing team of experts. He is, without doubt, at the top of his profession and his passion and dedication are traits which will fit perfectly at Southfields as we continue to grow."
Domingo is also a visiting lecturer in cardiology and respiratory medicine at the Catholic University of Valencia, while he is an active clinical researcher and has published widely in many areas of cardiology and respiratory medicine. His areas of special interest are arrhythmias and interventional cardiology.
For more information about Southfields Veterinary Specialists, go to www.southfields.co.uk.
Thermo-insulated wellington boots to keep feet warm on farms during winter time are being launched by Bekina of Belgium in the UK and ROI.
Like the Bekina Steplite X boots designed for general farm work, the Thermolite cold weather wellie is moulded from polyurethane rather than traditional rubber or PVC. However, the Thermolite wellie also has extra thick uppers and soles, making them suitable for use by farmers and vets in temperatures down to minus 40C.
Wide fitting for extra comfort, Bekina Thermolites are supplied with a free pair of removable, insulated insoles. They are also available with safety toecaps.
For details Freephone AgriHealth 0800 731 2490,or visit http://www.bekina.be/
John Davies and Tom Lonsdale MsRCVS both objected to edits made by the College to their candidate statements.
Mr Davies explained in his statement how he'd been subject to "bewildering, unfounded and damaging allegations" from two veterinary nurses, one of which he says resulted in his dismissal from a practice at which he was a partner. He went on to explain how, in addition to taking the dismissal case to an employment tribunal and winning, he had also raised concerns with the College about the nurses who'd made the allegations against him. Mr Davies outlined the way he felt that the RCVS mismanaged his case and how that had driven him to stand for Council to try and address the grave concerns he now had about the governance of the profession. However, the Returning Officer redacted the details on the grounds that they were considered to be defamatory and/or factually misleading.
The main grounds for Mr Lonsdale’s challenge was that the election had been furthered by corrupt practices, namely undue influence (all in terms of the Misrepresentation of the People Act 1983). In addition, the Returning Officer edited Mr Lonsdale’s candidate statement before circulation to the electorate, refusing to include hypertext links and removing references that the Returning Officer believed to be defamatory. The Returning Officer also declined to publish his ‘Quiz the candidates’ video on the RCVS website and/or YouTube channel when requests to make minor amendments considered defamatory were refused.
Both challenges were lodged with the RCVS last July, after which the College set up a Challenge Committee in accordance with the election challenge procedure, approved by Privy Council. It comprised three members of Council nominated by RCVS President Stephen May.
Sitting with one of the RCVS Legal Assessors – Mr Richard Price OBE QC – the Challenge Committee was required to decide whether to declare the election void, based on whether the alleged irregularity in question rendered the election substantially not in accordance with the RCVS Council Election Scheme, or that the irregularity concerned significantly affected the result of the election (in which Mr Lonsdale and Mr Davies came 15th and 16th respectively out of 16 candidates).
Following written submissions from both the RCVS and Mr Davies, the Challenge Committee dismissed Mr Davies’s challenge, stating that there was no irregularity in the conduct of the election on the part of the Returning Officer, and that there was no valid basis for challenging the validity of the election.
The Challenge Committee (comprising the same members as for Mr Davies’s challenge) also dismissed Mr Lonsdale’s challenge, stating that it considered it to be 'totally devoid of merit'.
Prior to reaching this decisions, however, two preliminary challenges made by Mr Lonsdale were also considered and dismissed.
The first related to the members of the Challenge Committee, whom Mr Lonsdale argued should stand down on the basis of actual or apparent bias based on his allegations of connections with the pet food industry.
The Committee considered that a fair-minded and informed observer, having understood the facts, would conclude that the connection of committee members to the pet food industry were '….remote, indirect and, in the case of one panel member, virtually non-existent'.
Each committee member was satisfied that there was '…no real possibility of their judgement being distorted or influenced by any interest in, or links with, the pet food industry.'
The second challenge was to The Legal Assessor, who had been appointed to advise the Committee. Mr Lonsdale had alleged that Mr Price had displayed bias in the way that he had given advice to the Committee in relation to the challenge to the Committee membership. This was also dismissed.
In a statement given to the Veterinary Record earlier this year, the College said:
"In 2017, our commitment to equality for our LGBTQ+ employees, members of the professions and other stakeholders, was cemented when we became a Stonewall Diversity Champion, with the aim of ensuring that all people in the community are accepted, without exception, within the veterinary professions.
In subsequent years this commitment has been demonstrated by the establishment of our Diversity & Inclusion Group, for which LGBTQ+ representation is a key component and has been incorporated into both our internal and external diversity and inclusion strategies.
Focusing on our internal diversity and inclusion strategy, the insight from Stonewall and our internal LGBTQ+ group, has aimed to make the RCVS a safe space for people from the LGBTQ+ community by creating a fully inclusive workplace.
These insights have also fed into the profession-facing work of the Diversity & Inclusion Group and its strategy.
After six years as a Stonewall Diversity Champion, we have decided this year not to renew our contract with the organisation, on the basis that we feel we no longer need to work with an external organisation to continue to deliver on our commitment to equality, diversity and inclusion.
The RCVS will continue to demonstrate allyship and be a safe space for all groups within the LGBTQ+ community, as demonstrated by the fact we are creating a staff network representing RCVS colleagues from marginalised communities.
We may in future decide to work with another accredited organisation, but until the staff network is in place, no decisions have been made. For example, we have recently brought in a staff policy regarding how best to support RCVS employees who are going through the process of gender reassignment, reiterating the current legal position, how to report experiencing or witnessing transphobic discrimination, as well as advice for colleagues supporting those undergoing gender reassignment and those who have family members going through the process. We are grateful for Stonewall for working with us over the past six years and helping us, through its Workplace Equality Index, to finesse our policies and procedures in relation to LGBTQ+ rights and issues and drive forward our agenda to be a diverse and inclusive workplace and regulator."
To mark today's European Antibiotic Awareness Day 2010, the British Veterinary Association is warning veterinary surgeons in the UK that failure to use antimicrobials responsibly could result in their use being restricted.
The BVA promotes the responsible use of antimicrobials and last year published a poster and guidance for vets: 'Responsible use of antimicrobials in veterinary practice: the 8-point plan'. According to the association, the poster received very positive feedback from across the UK and from the Federation of Veterinarians of Europe (FVE).
Concerns regarding resistance to antimicrobials and antibiotics span both the human and animal medicine fields and in 2008 the Chief Medical Officer called for a ban on the use of certain types of antibiotics in animals in order to protect their activity in humans.
Furthermore some EU Member States already restrict the availability of antimicrobials to veterinary surgeons and adopt a strict formulary approach to the medicines that they can prescribe. The BVA says it is concerned that this trend will reach the UK and the freedom of vets to prescribe according to their clinical judgement will be restricted.
Harvey Locke, President of the BVA, said: "Antimicrobial resistance is an enormous problem for both human and animal health. As veterinary surgeons we have a duty to use these medicines responsibly for the good of animal health and welfare as well as public health.
"The BVA's poster on responsible use should be displayed in veterinary practices across the UK as a constant reminder, and I would urge all vets to refer to it.
"Failure to heed the message of responsible use could result in vets losing the right to prescribe certain medicines, which could have a significant impact on animal health and welfare.
"On Antibiotic Awareness Day our message to vets is clear: use them responsibly or lose them."
Elanco is highlighting new research which shows that using monensin in dairy cows at high risk of developing subclinical ketosis reduces curative antibiotic use by 25%.
According to the company, good herd management before calving is known to mitigate antimicrobial use in cows suffering from subclinical ketosis related conditions, but to date little research has quantified it.
The new research, by the University of Toulouse, was presented to leading cattle vets, academics and representatives of the pharmaceutical industry by veterinary cattle health specialist, Professor Didier Raboisson at the European Buiatrics Forum in Rome in October.1 It showed that using a monensin bolus in cows at high risk of getting subclinical ketosis led to a 25% reduction in antibiotics to treat and cure conditions associated with the metabolic condition.
Fiona Anderson MRCVS of Elanco said: "Responsible use of antimicrobials must be the target for veterinary medicine. Reducing use by whatever means could help improve the antimicrobial resistance situation. This new study shows that using monensin, which is available in the form of a Kexxtone bolus, is a powerful way to cut antibiotic use in the dairy herd. This is in addition to monensin already proven to be a valuable tool to reduce the risk of ketosis and subclinical ketosis and its associated losses in dairy herd productivity and profitability."
Subclinical ketosis is very common. It can affect up to 30% of cows in early lactation with a large variation between herds.2 It can be very costly for a dairy herd. A study from 2015 found that for a 100 cow herd with 30% ketosis, the direct and indirect costs can be around £10,416 or around £347 per affected cow.3
Cows affected by subclinical ketosis are at a higher risk of getting mastitis and metritis. They are also at higher risk of developing displaced abomasum, retained placenta and cystic ovaries and consequently face a higher culling risk. Subclinical ketosis also lowers milk production, reduces conception rates and lengthens calving intervals.4
If ketosis is an issue in a dairy herd, targeted administration of monensin in a Kexxtone bolus to cows at high risk of developing ketosis reduces the incidences of ketosis by 74%.6
The bolus is given three weeks before calving and provides coverage during the main risk period for the condition. Kexxtone uses monensin to improve rumen function and increase glucose delivery. This ultimately increases the energy available and buffers the dairy cow against the tendency to drop into negative energy balance.5
To make a big difference to clients’ profitability, Fiona encourages vets to not just consider the traditional nutritional intervention and the emergency treatment of ketosis cases, but to develop an effective strategy to highlight cows at risk of subclinical ketosis and to take targeted preventative action. She said: "Vets who can offer positive interventions to subclinical ketosis and its associated losses in the dairy herd are going to be increasingly important to their clients’ herd health planning."
References:
According to statistics from the RCVS, almost 40% of veterinary surgeons that have registered in the UK since 2005 qualified from veterinary schools elsewhere in the EU.
Of course, it's not just in general practice that veterinary surgeons and veterinary nurses from other EU member states make such an important contribution. They work across all areas of veterinary science, including the fields of animal health and welfare, animal disease surveillance, scientific research and education, wildlife conservation, and public health and food safety.
Figures from the Veterinary Public Health Association (VPHA) estimate that over 90% of vets in meat hygiene services are non-British EU citizens.
To highlight the impact of Brexit on the veterinary profession, the BVA has written to the Secretary of State, Liz Truss MP, and to Ministers in Scotland, Wales and Northern Ireland, requesting an early statement to the effect that non-British EU vets and vet nurses who are currently living, studying or working in the UK will continue to be able to do so in future.
BVA is also seeking reassurance for UK veterinary professionals working and studying in other EU member states.
BVA President Sean Wensley said: "It is not yet possible to comment on the reality of ‘Brexit’ since much will depend on forthcoming negotiations and the decisions that will be taken by the Government regarding, for example, whether or not to maintain existing EU legislation and rules. However, we recognise that these unanswered questions are having a profound impact on many of our members – particularly members who are non-British EU citizens, or have family members who are, and members who work alongside colleagues from other European Member States."
In the letters, Mr Wensley wrote: "I am sure there are many significant issues that your Department needs to consider [and] given the profound personal impact that the uncertainty caused by the referendum outcome is having on some of our members, we wanted to contact you at the earliest opportunity. In the forthcoming negotiations about the future relationship between the UK and the EU, we strongly urge you to make the case for all EU citizens and EU-qualified veterinary surgeons and nurses to have ongoing rights to live, work and study in the UK."
In the letter to the Northern Ireland (NI) Minister of Agriculture, Environment and Rural Affairs Michelle McIlveen MLA, the BVA President and BVA NI Branch President Seamus O’Kane highlighted NI’s land border with EU member state the Republic of Ireland and called for the maintenance of the Common Travel Area to facilitate movement in an all-island context for both work and study purposes.
VPHA President Lewis Grant said: "Due to the particular focus on public health in many European veterinary degree courses, EU vets make an enormous contribution to both public health and animal health and welfare in the UK - often behind closed doors, monitoring and protecting public health in Approved Premises as well as welfare at slaughter to ensure slaughterhouses meet the standards that are required by law and expected by the public. Without their input and expertise, it would be difficult to ensure that Statutory requirements within the food industry are complied with."
Led by Jacques Ferreira, an RCVS and European Specialist in Veterinary Anaesthesia and Analgesia (pictured right), the new clinic will provide a bespoke pain management plan for pets referred both by external first opinion practices or internally by colleagues in other disciplines at the centre.
Jacques, who joined Willows in 2018 having previously lectured in Veterinary Anaesthesia at the University of Liverpool after specialising in the same subject in his native South Africa, said: "Just as with humans, our pets are living longer and, with that, there is an increased risk of developing chronic pain conditions.
"Traditionally, the most common patients are cats and dogs with chronic joint disease such as osteoarthritis but patients with a history of back problems and trapped nerves, cats with chronic cystitis and even those with some forms of cancer may benefit.
"We will work with first opinion vets who refer their patients to us, as well as internal referrals. The management of chronic pain is obviously ongoing but the aim for us would be to get to a stage where pain is effectively managed through the most appropriate avenue and check-ups are only needed every few months.
For more information, visit www.willows.uk.net.
The five-part series, which is hosted on Elanco’s customer portal MyElanco.co.uk, covers topics including managing social media communities, how to build a presence using social media advertising and how to respond to new regulations around personal data.
According to a report on Bloomberg, Facebook is reported to be on track to have 32.6 million regular users in the UK despite its falling audience of younger users. Meanwhile Instagram's UK user base was believed to be 16.7 million at the end of 2017. Hence why 81% of small and medium businesses are reported to use some kind of social platform.
Elanco Customer Experience Manager Matthew Rowe said: "The global popularity of social media sites means people now expect businesses to have a social media presence and veterinary practices are no different.
"More veterinary practices are launching business profiles, recognising how vital it is to have a social presence so they can engage with their clients outside of the consultation room. But we realise that it can seem like an intimidating and complex process.
"The workshops have been created to help more vet practices get started with social media and gain more confidence to make the most out of it for the benefit of their business."
To watch the videos, register at MyElanco.co.uk and visit: https://www.myelanco.co.uk/CPD/video-workshop-part1
Proposals being considered include insisting that dog breeders only sell puppies they have bred themselves and demanding that puppies are shown alongside their mother before sale.
Another proposal is to make it illegal to complete the sale of a puppy unless the new owner is present, thereby preventing online sales.
In addition, the government plans to regulate the advertising of all pets, making it a requirement for licensed sellers to display their licence number, the country of origin and the country of residence of any pet advertised for sale.
Measures to tackle puppy smuggling across borders will also be explored, alongside measures to address the breeding of dogs with harmful genetic disorders.
The Government says legislation introducing these proposals could be brought forward early in the New Year.
Prime Minister Theresa May said: "Any unscrupulous mistreatment of animals is disturbing – so in our drive to achieve the highest animal welfare standards in the world, we continually look at what more can be done. The arrival of a happy, healthy puppy, as I know myself, is a memorable time for a family – but it’s absolutely right we do everything we can to eradicate animal cruelty from our society. The proposals my government is developing will be an important step forward."
Environment Secretary Michael Gove said: "At this time of year it is all too easy to be moved by images online or adverts in the local press advertising new born puppies looking for a home for Christmas. But what we don’t see is all too often a sad history of mistreatment and malpractice. That is why we are looking at how we can go further to crack down on unscrupulous breeders so pet owners will have no doubt their new dogs have had the right start in life.
"This is one part of our efforts to ensure we have the highest animal welfare standards in the world. We have also ensured CCTV cameras will be mandatory in all slaughterhouses and will increase prison sentences from six months to five years for animal abusers."
In addition, the Government has confirmed that it will be taking forward proposals already put out for consultation earlier this year. They include a ban on the sale of puppies and kittens under the age of eight weeks, which will now extend to include rabbits, as well as compulsory licensing for anyone in the business of breeding and selling dogs.
Photo: Litter of Terrier Mix Puppies Playing in Dog Bed Outside on Wooden Deck, Shutterstock/Anna Hoychuk
The disease had been identified as a priority by the Wales Animal Health and Welfare Framework Group.
Further details will be announced in the coming months following ongoing discussions with industry representatives.
The Minister said: "Sheep scab has significant economic consequences for sheep producers and animal welfare issues for sheep. It is one of the most contagious disease of sheep in Wales and eradicating it is a priority for us and the industry.
"I’m pleased to be able to announce £5m Rural Development Programme funding will be used to help support the industry tackle the disease. Eradicating the disease has the potential to deliver significant lasting economic benefits for the sector at a particularly challenging time as we prepare to leave the European Union."
Neurodiversity Celebration Week is a worldwide initiative that challenges stereotypes and misconceptions about neurological differences, and the neurodiversity resource hub (www.vetmindmatters.org/resources/) aims to help members of the veterinary professions better understand how, for over one million people in the UK, neurological differences mean they learn and think in a way that is different to what is considered ‘neurotypical’.
Among the resources contained in the hub is information about neurological conditions closely associated with neurodivergence such as attention deficit hyperactivity disorder (ADHD), autism, dyspraxia and dyslexia, as well as information for employers about neurodiversity, including inclusive working tools and sources of government support.
A new ‘kite’ with six new modules are also being added to the MMI Kite App – a specialist microlearning platform for topics related to veterinary wellbeing – that deal specifically with issues related to neurodiversity. The six modules cover: what is neurodiversity; the importance of talking about neurodiversity; different types of neurodiversity; bespoke considerations for neurodivergent individuals; how neurodivergence can lead to innovation through thinking differently; and, exploring further how different brains work and how we can make our brains work best for us.
The College is also publishing a blog on the resource website by Dr Kirstie Pickles, Clinical Assistant Professor in Equine Medicine at the University of Nottingham, about her current MMI-funded research investigating the various workplace stressors that affect autistic veterinary professionals and what adjustments can be introduced to mitigate these stressors.
Lastly, at BSAVA Congress on Saturday 26 March between 3pm and 4pm, the RCVS has organised a discussion session on neurodiversity.
The discussion will be led by Roxanne Hobbs, a consultant in workplace inclusion particularly around neurodiversity, and will look at how to nurture and cultivate neurodiversity in the veterinary professions.
Lisa Quigley, Mind Matters Manager, said: “As a project focused on the mental health and wellbeing of veterinary professionals, the Mind Matters project has a commitment to recognising and providing a space for all forms of diversity, and so we are very glad to be supporting Neurodiversity Celebration Week again this year.
“We hope that our neurodiversity resource hub and our other initiatives during Neurodiversity Celebration Week will be useful source of information for everyone and will aid people in understanding neurodivergence, how it can manifest and how it can be supported in the workplace and educational settings.”
Lucy and Rosanna have joined the business in hybrid positions as Novice OVs and will do this alongside working in a clinical practice.
The company says this is a significant milestone for the industry, which has relied on overseas talent for many years.
Eville & Jones says it has now developed a compelling proposition for UK new graduates who want to combine OV work with traditional clinical practice, and vets looking for a lifestyle change or a move away from practice, working flexibly in export certification, abattoir work, certification against standards, or small animal vaccination.
Charles Hartwell, chief executive officer of Eville & Jones said: “The team at Eville & Jones has spent two years developing an attractive proposition to encourage UK-educated veterinary surgeons to consider a career in this field, whether combined with traditional clinical practice, or stand alone.
"We wish Lucy and Rosanna the best of luck and hope they become trailblazers for many others to follow in their footsteps.”
Lucy said: “I’m really excited to be starting my career in veterinary public health where, as an OV, you can positively affect the lives of 1000’s of animals."
Rosanna added: “I’m really proud to have joined the veterinary industry this summer; OVs are instrumental in monitoring and safe-guarding animal welfare in a way that many vets don't realise."
Alice and Mariella, who co-authored the book Cracking the Menopause, met with MPs earlier this month to present the goals of their campaign: education for all on the menopause, an end to scaremongering, prescribing women with the correct medication and making HRT affordable and accessible to all.
Vets Now says 88% of its 1800 employees are women, 28% of whom are aged over 40, when they could be perimenopausal, menopausal or postmenopausal.
The company's new app offers its employees video consultations with health experts, health and fitness programmes, and support with mental health and nutrition.
Vet's Now says it's the starting point for a wider menopause support plan being launched later in the year which will include steps to help manage mental wellbeing at work, menopause support hubs and encouraging a culture which talks honestly about menopause.
Laura Black, Head of Health, Safety and Wellbeing, said: “Women over 50 are the fastest growing demographic in the workplace and sadly it’s estimated that almost 900,000 women in the UK have quit their jobs due to the menopause.
“We are committed to creating an understanding workplace for employees going through the perimenopause and menopause and want to make sure they feel supported by us at all times.
“We've launched Peppy to help our colleagues take control of their health and get the answers they need from experts, anytime, anywhere.
"The app is free to access for all employees and their partners.
“We’ve been working hard on formulating a menopause support package for staff over the past couple of years and we’re really proud that we’re one of the first major veterinary businesses to make this step change.
"We’d encourage other businesses in the sector to look at similar plans for their colleagues.”
While the drive to launch Peppy was initially to support the Vets Now Menopause policy, it also provides support for fertility, pregnancy, early parenthood and men’s health.
For more information on Peppy visit www.peppy.health.
Prior to joining Fitzpatrick Referrals, Gerard was a Senior Lecturer in Internal Medicine at the University of Glasgow as well as Head of the Emergency Service and Director of both the Internship and ECVIM Residency Programmes. He is also a European and Royal College Recognised Specialist in Internal Medicine, and recently became one of few specialists in the world to have completed a 12 month Fellowship in Interventional Radiology at the Animal Medical Center in New York.
Gerard said: "When I returned to the UK, it was a natural fit for me to join Fitzpatrick Referrals. The team all share the same ethos and together I know we will be able to offer a truly world-class service to our patients and their family. I genuinely believe we will be able to change what is accepted as the gold standard of care for animals in the UK."
Fitzpatrick Referrals says its interventional radiology service performs minimally invasive procedures that are often considered the standard of care in human medicine, providing options for veterinary patients where conventional therapies are not associated with the best outcome.
Clinical Director of Oncology and Soft Tissue, Professor Nick Bacon said: "Gerard joining the team in Guildford opens new doors for our patients but more importantly we hope the disciplines of veterinary oncology and soft tissue surgery as a whole. He brings huge experience in interventional radiology solutions for portosystemic shunts, tracheal collapse and urinary calculi obstruction. Gerard is also key to developing our cancer care. Progress is not about ever bigger treatments chasing a cure; it can just as easily mean delivering palliative or curative-intent treatments in smarter ways, with less side-effects and lower morbidity. I am looking forward to watching our treatments evolve for a variety of tumours including urinary, liver, lung and head and neck. No cancer treatment is perfect, but we are striving for the best we can for the patient in front of us."
Noel Fitzpatrick said: "It remains my objective to build the greatest team of super-specialists on planet earth where we can offer all of the options to all of the animals and the families that love them all of the time. Gerard has a unique skill set that will not only complement our growing team, but will enhance the spectrum of treatments we can offer and which the families of animals throughout the UK and beyond really want. Increasingly people want the same level of care for their dogs and cats as we have for ourselves and our goal is to deliver exactly that with the very best team and facilities in the world today."
Fitzpatrick Referrals will be holding a Partners in Care CPD session on 25th May inviting vets to meet Dr Gerard McLauchlan and discover more about the interventional radiology service. To register your interest, contact Sarah on SarahC@fitzpatrickreferrals.co.uk.
Reporter Andy Davies spoke to Charlotte Debbaut MRCVS, a veterinary surgeon from Belgium working at the Tindale Veterinary Practice in Gloucestershire, where there are 13 vets with eight different nationalities. He also interviewed Matthew Pugh MRCVS and Ovidiu Oltean MRCVS from Belmont Veterinary Centre, a mixed practice in Hereford which employs five foreign nationals out of a team of 13 veterinary surgeons.
Finally, he talked to John Blackwell MRCVS at Brownlow Veterinary Group in Shropshire, where Brexit had already caused a Croatian member of his team to refuse a permanent position and return to Ireland.
Congratulations to the RCVS and BVA press offices, who will have been hard at work behind the scenes.
See: https://www.channel4.com/news/brexit-affecting-vet-recruitment
CVS says the new hospital, which will be based at Central Park, Avonmouth, will be custom-built with uniquely designed facilities, state-of-the-art diagnostic tools such as MRI and CT scanners, and a cutting-edge stereotactic linear accelerator for radiotherapy in cancer treatment, the only one of its kind for pets in England.
The hospital, which will open next summer, will employ over 100 people led by a team of Specialist veterinary surgeons and supported by residents, interns and registered veterinary nurses.
Planning permission has been granted for the project, and CVS is now appointing building contractors.
Richard Fairman, CEO of CVS Group, said: "We are extremely excited to be developing this innovative new specialist veterinary hospital in Bristol, providing the best animal care to pet owners across the South West. With state-of-the-art equipment and some of the highest qualified veterinary professionals, we are confident that the site will act as a centre of excellence in the veterinary world, and be a leader in Europe for cancer treatments.
"The new hospital signals our commitment to investing in cutting-edge technology to bring cancer treatment in pets to the next level. It will provide a number of employment opportunities and secure specialist veterinary skills in the Bristol area. We look forward to finalising development plans and opening the doors to pet owners in 2022."
Is it right to keep treating an animal just because the technology is available? This is a question that Noel Fitzpatrick, aka the BBC's Bionic Vet, will be addressing at this year's British Veterinary Association (BVA) Congress, in a debate titled 'Treatment too far?' on Friday 24th September at 4pm.
The BVA Congress will take place in the Glasgow Marriott Hotel on 23-25 September 2010 under the theme 'Vets and the Public Good', looking at the role of veterinary surgeons in all aspects of society.
Organisers say that Congress will be a truly Scottish event, led by BVA President Professor Bill Reilly (born and bred in Glasgow and a graduate of Glasgow Vet School) with clinical CPD sessions delivered by Scotland's finest research and academic institutions.
This year also boasts a full non-clinical stream of lectures tackling employment law, management skills, and mental health.
Highlights include:
Vets and the public good: the broader perspective (Wooldridge Memorial Lecture)Professor Stuart Reid, Dean of the Faculty of Veterinary Medicine at the University of Glasgow will deliver the keynote Wooldridge Memorial Lecture. He will consider the extent of the veterinary contribution to society, which extends into areas such as public health, infectious disease control, scientific research, public education, food production, national security, disaster management, care of the environment, and international development. (Fri 24 Sept, 12.15-13.25)
Pets and society: turning a blind eye to abuse?It is nearly a decade since attention began to be drawn to evidence of links between animal abuse and domestic violence towards humans. This session will examine the dilemmas confronting practising vets, asking at what stage should suspicions of abuse be reported and to whom? (Fri 24 Sept, 11.00-12.00)
Four into one must go Following last year's highly popular session, the UK's four CVOs will again come together to debate and discuss current issues in veterinary politics and animal health and welfare, under the chairmanship of BVA President Professor Bill Reilly. (Sat 25 Sept, 9.30-10.30)
Responsibility and cost sharing - where are we now? This session will include a progress report from Rosemary Radcliffe, chair of the independent committee that will be advising the Government on establishing new arrangements in England, and a discussion of what this might mean for practising vets. (Sat 25 Sept, 16.00-17.00)
In addition there will be contentious issue debates on the role of vets in promoting farm animal welfare, the practical difficulties of current dangerous dogs legislation, and the role of vets as experts witnesses in cases of abuse or neglect.
Under the theme of 'public good' there will be a session looking at the role of vets in international development 'Improving the livelihoods of farmers in resource-poor countries', and a session on the zoonotic infections that impact on public health, such as E. Coli and Chlamydia, and what organisations like open farms can do to minimise the risks.
Professor Bill Reilly, President of the BVA, said: "Vets and the public good has been the theme of my presidential term because I believe that the role of vets in all aspects of society should receive more attention.
"Our Congress programme combines the world-renowned expertise of Scotland's academic and research institutes with significant topical issues of debate to capture the widest possible definition of the veterinary contribution to society."
For more information on BVA Congress 2010 (including the full agenda and online registration) visit the BVA website www.bva.co.uk/congress
Virbac has announced that Ovarid is back in stock following the resolution of a manufacturing problem.
The megestrol acetate tablets are indicated for the postponement or prevention of oestrus and the treatment of hypersexuality in male dogs. In cats they are recommended for the prevention or postponement of oestrus and the treatment of miliary dermatitis and eosinophilic granulomata.
Virbac says that because the product is relied on by the owners of many cats suffering from miliary eczema, it has worked to ensure that their welfare is not compromised by recalling unused Ovarid stock from practices to ensure that it could still be provided to those contacting them with emergency cases since the outage began in February.
Senior Product Manager Chris Geddes MRCVS said: "I'd like to express my thanks to practices for bearing with us and particularly to those which returned unused product. This meant that we were able to supply emergency supplies for the treatment of miliary eczema to every practice that asked for it. We also managed to help out some zoos which needed supplies for frisky sea lions and lions."
Ovarid is available in 20mg and 5mg tablets.
Miss Johnson was convicted at North Somerset Magistrates’ Court following a guilty plea of the offence of theft by employee in December 2023, after she stole buprenorphine belonging to Yatton Vets earlier that year.
She was sentenced to a fine of £120, a surcharge of £48, and costs of £85.
There were four further charges against Miss Johnson.
Charge one related to Miss Johnson stealing 5ml of methadone in December 2022 from her employer, Vets4Pets in Bristol, and injecting herself with the methadone.
The police investigated the incident and Miss Johnson accepted a conditional caution for the theft, the condition being she should attend a drug awareness course.
Charge two related to Miss Johnson dishonestly taking a syringe of methadone in August 2023 from her employer, the Langford Small Animal Hospital, and injecting herself with it.
Charge three related to two dates in September 2023 when she dishonestly took methadone, gabapentin and buprenorphine from Yatton Vets, her then employer, injecting herself with the buprenorphine and then working when unfit to do so.
Miss Johnson was later convicted of theft in relation to the buprenorphine (charge five).
Charge four related to an incident in November 2023, when Miss Johnson dishonestly took a syringe of buprenorphine from Bristol PDSA, for the purposes of self-administration, and was dishonest both to other members of staff and in the clinical records about the circumstances of taking the buprenorphine.
Charge five was in relation to Miss Johnson’s criminal conviction.
At the outset of the hearing, Miss Johnson admitted all charges in their entirety.
Having reviewed all the evidence and taken Miss Johnson’s admissions into account, the Committee found each of the charges proved.
After the criminal proceedings had finished and had been reported to the College, Miss Johnson wrote a letter expressing her deepest apologies to both the RCVS and the profession.
Within this she also made it clear that she took full responsibility for her actions.
In a later statement, she added that she had tried to use the experience to learn and improve in every aspect of her career and life and did not want to defend her behaviour.
Within this statement she also retracted a previous request to resign from the register, stating that she would accept any outcome to the investigation.
In deciding whether the proved charges amounted to serious professional misconduct, the Committee took the following aggravating factors into account:
The Committee identified no mitigating factors and concluded that for each of the individual charges Miss Johnson’s conduct fell far short of the conduct expected of a member of the profession and that each of the charges one to four amounted to serious professional misconduct.
In relation to charge five, the criminal conviction, the Committee noted that the nature and the circumstances of the offence involved dishonesty, abuse of her professional position regarding access to controlled drugs, breach of her employer’s trust, and that the misconduct took place notwithstanding an investigation by the police for similar conduct in December 2022.
The Committee therefore concluded that charge five rendered Miss Johnson unfit to practise.
When deciding on a sanction, the Committee took into account mitigating factors, which included:
The Committee found no further aggravating factors at this stage.
Kathryn Peaty, chairing the Committee and speaking on its behalf said: “The Committee considered that the overall misconduct proved so serious and was incompatible with remaining on the register.”
She added: “The Committee accepted that Miss Johnson was currently likely to be drug-free on the basis of her evidence and that of her referee, but it noted that independent testing proving she had been drug free for any period of time was not available to it.
"Furthermore, Miss Johnson had been unable to demonstrate that she had worked without any incident recently as she had accepted she had been dismissed from her recent job.
“Having taken into account all of the aggravating and mitigating factors, and balancing the public interest and the need to uphold and maintain standards within the profession, and having decided that Miss Johnson’s insight was limited, the Committee concluded that the sanction of ‘removal’ was the only proportionate sanction it could impose in this case.
"It also decided that such a sanction maintained public confidence in the veterinary profession, safeguarded animal welfare and protected the public from any future risk of repetition of similar behaviour.
“The Committee therefore directed that the Registrar remove Miss Johnson’s name from the register of veterinary nurses forthwith.”